Stoke Therapeutics, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 17
EBIT TTM (mln): -119
index 0 1 2 3 4 5 6 7
Rok finansowy 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 12 9 37
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% 0.0% inf% -29.2% 316.3%
Marża brutto 0.0% 0.0% -inf% -inf% -inf% 71.5% 46.1% 100.0%
EBIT (mln) -6 -13 -36 -53 -86 -104 -115 -101
EBIT Δ r/r 0.0% 130.1% 179.1% 48.7% 62.3% 21.3% 10.0% -11.7%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% -841.2% -1307.2% -277.3%
Koszty finansowe (mln) 0 0 0 0 0 3 10 0
EBITDA (mln) -5 -13 -36 -53 -86 -104 -110 -101
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% -841.2% -1253.3% -277.3%
Podatek (mln) 0 0 -4 -2 -1 -8 0 0
Zysk Netto (mln) -6 -13 -29 -51 -85 -93 -105 -89
Zysk netto Δ r/r 0.0% 125.3% 127.8% 77.4% 67.4% 9.9% 12.4% -15.0%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% -750.6% -1192.5% -243.4%
EPS -0.43 -0.53 -1.59 -1.51 -2.31 -2.39 -2.38 -1.65
EPS (rozwodnione) -0.43 -0.53 -1.59 -1.51 -2.31 -2.39 -2.38 -1.65
Ilośc akcji (mln) 13 24 18 33 37 39 44 54
Ważona ilośc akcji (mln) 13 24 18 33 37 39 44 54
Waluta USD USD USD USD USD USD USD USD